From: Boris Nikolic
To: Jeffrey Epstein <jeeyacation@gmail.com>
Subject: FW: Foundation Medicine Prices Initial Public Offering of Common Stock
Date: Tue, 24 Sep 2013 22:13:42 +0000
It is priced much higher. 18 - they were thinking 12! This places valuation much higher. And just watch it will go
through the roof t:
Sent from my Windows Phone
From: Foundation Medicine
Sent: 9/24/2013 5:58 PM
To: Boris Nikolic
Subject: Foundation Medicine Prices Initial Public Offering of Common Stock
;`'ogr2
Sept. 24. 2013 21:50 UTC
Foundation Medicine Prices Initial Public Offering of Common Stock
CAMBRIDGE, Mass.—(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced the pricing of its initial public
offering of 5,888,888 shares of common stock at a price of $18.00 per share, before underwriting discounts. All of the
common stock is being offered by Foundation Medicine. In addition, the underwriters have a 30-day option to purchase
up to an additional 883,333 shares of common stock from Foundation Medicine at the public offering price, before
underwriting discounts. The company's shares are expected to begin trading on The NASDAQ Global Select Market on
Wednesday, September 25, 2013 under the trading symbol "FMI."
Goldman, Sachs & Co. and NI Morgan Securities, LLC acted as joint book-running managers of the offering. Leerink
Swann LLC and Sanford C. Bernstein & Co., LLC acted as co-managers. A copy of the final prospectus relating to this
offering may be obtained, when available, from: Goldman, Sachs & Co., Attention: Prospectus Department, 200 West
Street, New York, NY 10282, or by telephone at (866) 471-2526, facsimile at , or e-mail at
or MI Morgan Securities LLC, do Broadridge Financial Solutions, 1155 Long Island Avenue,
Edgewood, NY 11717. or by telephone at (866) 803-9204.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission
on September 24, 2013.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to
egistration or qualification under the securities laws of any such state or jurisdiction.
Contacts
Media — Foundation Medicine
Dan Budwick
Pure Communications, Inc.
Or
Investors — Foundation Medicine
Matt Clawson,
EFTA00872569
Source: Foundation Medicine, Inc.
View this news release online at: ;Powered by Business Wire
EFTA00872570